Cargando…

1,25(OH)(2)D(3) inhibits osteogenic differentiation through activating β-catenin signaling via downregulating bone morphogenetic protein 2

The present study explored whether bone morphogenetic proteins (BMPs) and Wnt/β-catenin signaling pathways were involved in the 1,25(OH)(2)D(3)-induced inhibition of osteogenic differentiation in bone marrow-derived mesenchymal stem cells (BMSCs). To evaluate the osteogenic differentiation of BMSCs,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Han, Xiaofeng, Zhu, Naifeng, Wang, Yihan, Cheng, Guangqi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7646955/ https://www.ncbi.nlm.nih.gov/pubmed/33173996 http://dx.doi.org/10.3892/mmr.2020.11619

Ejemplares similares

Association among plasma 1,25(OH)(2)D, ratio of 1,25(OH)(2)D to 25(OH)D, and prostate cancer aggressiveness
por: Ramakrishnan, Swathi, et al.
Publicado: (2019)

Role of bone morphogenetic protein-2 in osteogenic differentiation of mesenchymal stem cells
por: SUN, JIAN, et al.
Publicado: (2015)

Vitamin D and 1,25(OH)(2)D Regulation of T cells
por: Cantorna, Margherita T., et al.
Publicado: (2015)

Promoting effect of 1,25(OH)(2) vitamin D(3) in osteogenic differentiation from induced pluripotent stem cells to osteocyte-like cells
por: Kato, Hiroshi, et al.
Publicado: (2015)

Multiple Sclerosis Patients Show Lower Bioavailable 25(OH)D and 1,25(OH)(2)D, but No Difference in Ratio of 25(OH)D/24,25(OH)(2)D and FGF23 Concentrations
por: Vlot, Mariska C, et al.
Publicado: (2019)

miR-204 inhibits the osteogenic differentiation of mesenchymal stem cells by targeting bone morphogenetic protein 2
por: Jiang, Xiaofeng, et al.
Publicado: (2020)

Antidepressants differentially related to 1,25-(OH)(2) vitamin D(3) and 25-(OH) vitamin D(3) in late-life depression
por: Oude Voshaar, R C, et al.
Publicado: (2014)

Circulatory 25(OH)D and 1,25(OH)(2)D as differential biomarkers between multiple system atrophy and Parkinson's disease patients
por: Ogura, Hiromu, et al.
Publicado: (2021)

Effects of 1,25(OH)(2)D(3) and 25(OH)D(3) on C2C12 Myoblast Proliferation, Differentiation, and Myotube Hypertrophy
por: van der Meijden, K., et al.
Publicado: (2016)

Modulation of osteogenic differentiation by Escherichia coli-derived recombinant bone morphogenetic protein-2
por: Kim, Nam-Hyun, et al.
Publicado: (2022)

Bone morphogenetic proteins 2, 6, and 9 differentially regulate the osteogenic differentiation of immortalized preodontoblasts
por: Cao, Yuying, et al.
Publicado: (2020)

Osteogenic Enhancement Between Icariin and Bone Morphogenetic Protein 2: A Potential Osteogenic Compound for Bone Tissue Engineering
por: Zhang, Xin, et al.
Publicado: (2019)

1,25-Dihydroxyvitamin D(3) (1,25(OH)(2)D(3)) Signaling Capacity and the Epithelial-Mesenchymal Transition in Non-Small Cell Lung Cancer (NSCLC): Implications for Use of 1,25(OH)(2)D(3) in NSCLC Treatment
por: Upadhyay, Santosh Kumar, et al.
Publicado: (2013)

Does Sevelamer Hydrochloride (Renagel) Influence 25(Oh)D3 and 1,25(Oh)2D3 Level in Haemodialysis Patients?
por: Strózecki, Pawel, et al.
Publicado: (2005)

25(OH)D(3) and 1.25(OH)(2)D(3) inhibits TNF-α expression in human monocyte derived macrophages
por: Rafique, Aisha, et al.
Publicado: (2019)

MON-LB74 The Problem of Measuring 1,25(OH)2 Vitamin D in Patients With High Levels of 25(OH) Vitamin D
por: Vieira, Jose Gilberto, et al.
Publicado: (2020)

25(OH)D-but not 1,25(OH)(2)D–Is an independent risk factor predicting graft loss in stable kidney transplant recipients
por: Zeng, Shufei, et al.
Publicado: (2023)

1,25-(OH)(2)D(3)/Vitamin D receptor alleviates systemic lupus erythematosus by downregulating Skp2 and upregulating p27
por: Liu, Dan, et al.
Publicado: (2019)

Hoxa2 Inhibits Bone Morphogenetic Protein Signaling during Osteogenic Differentiation of the Palatal Mesenchyme
por: Iyyanar, Paul P. R., et al.
Publicado: (2017)

The metabolism of 1,25(OH)(2)D(3) in clinical and experimental kidney disease
por: Turner, Mandy E., et al.
Publicado: (2022)

Bone Morphogenetic Protein Receptor in the Osteogenic Differentiation of Rat Bone Marrow Stromal Cells
por: Wang, Anxun, et al.
Publicado: (2010)

Maternal serum retinol, 25(OH)D and 1,25(OH)(2)D concentrations during pregnancy and peak bone mass and trabecular bone score in adult offspring at 26-year follow-up
por: Balasuriya, Chandima N. D., et al.
Publicado: (2019)

Vitamin D (1,25(OH)(2)D3) induces α-1-antitrypsin synthesis by CD4(+) T cells, which is required for 1,25(OH)(2)D3-driven IL-10
por: Dimeloe, Sarah, et al.
Publicado: (2019)

Bone morphogenetic protein 2-enhanced osteogenic differentiation of stem cell spheres by regulation of Runx2 expression
por: Min, Sae Kyung, et al.
Publicado: (2020)

Downregulation of the LncRNA MEG3 Promotes Osteogenic Differentiation of BMSCs and Bone Repairing by Activating Wnt/β-Catenin Signaling Pathway
por: Liu, Juan, et al.
Publicado: (2022)

Suppression of bone morphogenetic protein inhibitors promotes osteogenic differentiation: therapeutic implications
por: Heliotis, Manolis, et al.
Publicado: (2008)

1,25(OH)(2)D(3) downregulates the Toll-like receptor 4-mediated inflammatory pathway and ameliorates liver injury in diabetic rats
por: Wang, H., et al.
Publicado: (2015)

25(OH)D and 1,25(OH)D vitamin D fails to predict sepsis and mortality in a prospective cohort study
por: Ratzinger, Franz, et al.
Publicado: (2017)

Increased microRNA-93-5p inhibits osteogenic differentiation by targeting bone morphogenetic protein-2
por: Zhang, Ying, et al.
Publicado: (2017)

Bioactive Polyetheretherketone with Gelatin Hydrogel Leads to Sustained Release of Bone Morphogenetic Protein-2 and Promotes Osteogenic Differentiation
por: Zhang, Ruonan, et al.
Publicado: (2023)

1,25(OH)(2)D(3) Alters Growth Plate Maturation and Bone Architecture in Young Rats with Normal Renal Function
por: Idelevich, Anna, et al.
Publicado: (2011)

Calcium ion-induced formation of β-sheet/-turn structure leading to alteration of osteogenic activity of bone morphogenetic protein-2
por: Zhang, Wenjing, et al.
Publicado: (2015)

In vitro induction effect of 1,25(OH)(2)D(3) on differentiation of hair follicle stem cell into keratinocyte
por: Joulai Veijouyeh, Sanaz, et al.
Publicado: (2017)

1,25(OH)(2)D(3) Promotes the Efficacy of CD28 Costimulation Blockade by Abatacept
por: Gardner, David H., et al.
Publicado: (2015)

1,25(OH)(2)D(3) dependent overt hyperactivity phenotype in klotho-hypomorphic mice
por: Leibrock, Christina B., et al.
Publicado: (2016)

Recruitment, augmentation and apoptosis of rat osteoclasts in 1,25-(OH)(2)D(3) response to short-term treatment with 1,25-dihydroxyvitamin D(3)in vivo
por: Miao, Dengshun, et al.
Publicado: (2002)

Effects of bioactive glass S53P4 or beta-tricalcium phosphate and bone morphogenetic protein-2 and bone morphogenetic protein-7 on osteogenic differentiation of human adipose stem cells
por: Waselau, Martin, et al.
Publicado: (2012)

Addition of bone morphogenetic protein type 2 to ascorbate and β-glycerophosphate supplementation did not enhance osteogenic differentiation of human adipose-derived stem cells
por: CRUZ, Ariadne Cristiane Cabral, et al.
Publicado: (2012)

1,25(OH) (2)D(3) blocks IFNβ production through regulating STING in epithelial layer of oral lichen planus
por: Ge, Xuejun, et al.
Publicado: (2022)

Bone Morphogenetic Protein-2 Signaling in the Osteogenic Differentiation of Human Bone Marrow Mesenchymal Stem Cells Induced by Pulsed Electromagnetic Fields
por: Martini, Fernanda, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vajfa2jltv737vaerctd4nhbtk